COLOPLAST

Coloplast’s share fell 1.39% amid unsettled market sentiment, yet still up 11.6% YTD, highlighting resilience and a solid 200‑day SMA support amid sector volatility.

Coloplast shares dip amid mixed 2025‑26 earnings, yet hints at a turnaround; investors eye the upcoming call for deeper insight into its stable outlook.

Coloplast shares slip 1.1% as Danish healthcare stocks rally, but the company remains on a 11% uptrend since March with a 52‑week high near DKK 631.4.

Coloplast shares fell 1.12% to DKK 476 on the OMX Nordic Exchange, while analysts lift targets to DKK 480‑515 amid cautious optimism and a shift to defensive sectors.